By Stephen M. Hahn MD, Patrizia Cavazzoni MD, & Peter Marks MD, PhD – When the U.S. Food and Drug Administration learned of the novel coronavirus (COVID-19) and its potentially devastating effects, we acted swiftly to set the regulatory stage for drug and biologics manufacturers to develop products to treat this serious disease.Read More
By Matt Fisher – Responses to and really reopening plans as part of the effort to address COVID-19 have raised a number of privacy concerns. When privacy and healthcare come up together, the discussion inevitably turns to HIPAA.
By Samantha Young – Three months ago, the nation watched as COVID-19 patients overwhelmed New York City’s intensive care units, forcing some of its hospitals to convert cafeterias into wards and pitch tents in parking lots.
By Deirdre Ruttle – Technology is connecting patients to their healthcare needs as the COVID-19 crisis continues. Patient demands for convenient, secure and simple experiences combined with social distancing have spurred technology adoption.
By John Racine – Five Critical Issues Your Organization Can’t Afford to Overlook. Managing through this COVID-19 crisis has required healthcare systems to expand some aspects of their workforce and redeploy others virtually overnight.
National increase from 0.15 percent of medical claim lines in April 2019 to 13.00 percent in April 2020, according to new data from FAIR Health’s Monthly Telehealth Regional Tracker. The data represent the privately insured population, excluding Medicare and Medicaid.
The National Institute of Allergy and Infectious Diseases established new clinical trials network aiming to enroll thousands of volunteers in large-scale clinical trials testing vaccines and monoclonal antibodies intended to protect people from COVID-19.
By Phil Galewitz – Elliot Truslow went to a CVS drugstore on June 15 in Tucson, Arizona, to get tested for the coronavirus. The drive-thru nasal swab test took less than 15 minutes. More than 22 days later, the University of Arizona graduate student was still waiting for results.
By Gopal Khanna MBA – AHRQ’s Expertise Helps Identify Next Steps. While the COVID-19 pandemic has revealed troubling vulnerabilities in our healthcare system, it has also pointed to one area of immense benefit: telehealth.